Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway

Anti-inflammatory effect of the six compounds isolated from Nauclea officinalis Pierrc ex Pitard, and molecular mechanism of strictosamide via suppressing the NF-κB and MAPK signaling pathway in LPS-induced RAW 264.7 macrophages

(2017) DongYu Li et al.   JOURNAL OF ETHNOPHARMACOLOGY

Parkinson's disease: Autoimmunity and neuroinflammation

(2016) Armando De Virgilio et al.   AUTOIMMUNITY REVIEWS

MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies

(2016) Aparna Karthikeyan et al.   CURRENT MEDICINAL CHEMISTRY

Inflammatory Response in the CNS: Friend or Foe?

(2016) Marta Sochocka et al.   MOLECULAR NEUROBIOLOGY

Vanillin Attenuated Behavioural Impairments, Neurochemical Deficts, Oxidative Stress and Apoptosis Against Rotenone Induced Rat Model of Parkinson’s Disease

(2016) Chinnasamy Dhanalakshmi et al.   NEUROCHEMICAL RESEARCH

Challenges in detecting disease modification in Parkinson's disease clinical trials

(2016) Dilan Athauda et al.   PARKINSONISM & RELATED DISORDERS

Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease

(2016) Tianfang Jiang et al.   PROGRESS IN NEUROBIOLOGY

The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation

(2016) Anja Henn   ALTEX-Alternatives to Animal Experimentation

Neurosupportive Role of Vanillin, a Natural Phenolic Compound, on Rotenone Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells

(2015) Chinnasamy Dhanalakshmi et al.   Evidence-based Complementary and Alternative Medicine

Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson’s disease models are mediated by GPR109A-dependent mechanisms

(2015) Shou-Peng Fu et al.   Journal of Neuroinflammation

Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling

(2014) Rong-Pei Liu et al.   Journal of Neuroinflammation

Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington's disease

(2014) Surbhi Gupta et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models

(2013) Wenjiao Tai et al.   NEUROPHARMACOLOGY

Inflammation in Parkinson's disease: Cause or consequence?

(2012) Stanley H. Appel   MOVEMENT DISORDERS

Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin

(2012) Wei Shao et al.   NATURE

Evaluation of the antioxidant, anti-inflammatory and hepatoprotective properties of vanillin in carbon tetrachloride-treated rats

(2011) Mohamed Makni et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Gastrodin Inhibits Expression of Inducible NO Synthase, Cyclooxygenase-2 and Proinflammatory Cytokines in Cultured LPS-Stimulated Microglia via MAPK Pathways

(2011) Ji-Nan Dai et al.   PLoS One

Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays

(2010) Akihiro Tai et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Vanillin Improves and Prevents Trinitrobenzene Sulfonic Acid-Induced Colitis in Mice

(2009) S.-L. Wu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

(2009) Malú G. Tansey et al.   NEUROBIOLOGY OF DISEASE